2010
DOI: 10.1016/j.jpeds.2009.08.043
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasonographic Patterns of Reproductive Organs in Infants Fed Soy Formula: Comparisons to Infants Fed Breast Milk and Milk Formula

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
42
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
2
1

Relationship

5
4

Authors

Journals

citations
Cited by 56 publications
(45 citation statements)
references
References 24 publications
3
42
0
Order By: Relevance
“…E2 treatment resulted in significant decreases in body weight and increases in uterine wet weight. Total serum isoflavone concentrations after feeding SPI were 1.3 g/ml (36), comparable to levels found in infants after soy formula feeding (47). The major serum isoflavone metabolite was equol (20 -40%) followed by genistein (20 -30%) and daidzein (10 -20%).…”
Section: Organ Weights Serum E2 and Isoflavone Levelssupporting
confidence: 64%
See 1 more Smart Citation
“…E2 treatment resulted in significant decreases in body weight and increases in uterine wet weight. Total serum isoflavone concentrations after feeding SPI were 1.3 g/ml (36), comparable to levels found in infants after soy formula feeding (47). The major serum isoflavone metabolite was equol (20 -40%) followed by genistein (20 -30%) and daidzein (10 -20%).…”
Section: Organ Weights Serum E2 and Isoflavone Levelssupporting
confidence: 64%
“…However, in contrast to data generated with purified isoflavones, there is a long history of safe consumption of soy foods in Asian populations associated with health benefits including reduced risk of estrogen-dependent cancers including breast cancer and even reduced risk of tumor recurrence in breast cancer patients (1-5, 57, 58). Moreover, studies of reproductive organ development in soy formulafed compared with dairy formula-fed and breast-fed infants have observed no significant differences (24,36). Previous studies have suggested that the effects of purified isoflavones, such as genistein and soy products, are different in the mammary gland and that mammary effects of soy products are dependent on how the soy is processed, on developmental stage of exposure, and on the concentrations of endogenous estrogens (2,3,5,32,44,59).…”
Section: Discussionmentioning
confidence: 99%
“…This re-evaluation of soy infant formula, which has been in use in the US for over 50 yr and which is consumed by nearly 1 million infants/year, was motivated by a series of in vitro and in vivo results evaluating the estrogenic properties of the soy isoflavone genistein (31). Although epidemiological studies in human infants consuming soy formula revealed normal growth and development (13,55), there is a concern that infants consuming soy formula are exposed to dangerously high levels of genistein and are at increased risk for reproductive tract malformations and for estrogen-sensitive cancers such as breast and uterine cancer, similarly to children of women exposed to diethylstilbestrol in utero (49). Genistein and other soy-associated isoflavone phytochemicals, such as daidzein, and the daidzein metabolite equol have a structural similarity with estrogens and are able to bind weakly to the estrogen receptors alpha and beta (ER␣ and ER␤), with a preference for ER␤ (24,30).…”
mentioning
confidence: 99%
“…Although it is clear that pure isoflavones can have estrogenic actions in vitro and in vivo, there is little positive evidence that consumption of soy protein isolate (SPI), which is a complex mixture of proteins and Ͼ100 phytochemicals in addition to isoflavones, results in estrogenic actions in vivo in intact animals having endogenous circulating sex steroids (53). Moreover, there is a paucity of studies examining the potential estrogenicity of soy infant formula feeding in human infants (14,26).…”
mentioning
confidence: 99%